FdaApplication
ANDA 209912
Identifiers
- fda_app_no: ANDA209912
Properties
| Property | Value |
|---|---|
| applicant_name | GRAVITI PHARMACEUTICALS PRIVATE LTD |
| application_type | ANDA |
| approval_date | 2018-06-18 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ATORVASTATIN CALCIUM | ATORVASTATIN CALCIUM | EQ 80MG BASE | TABLET;ORAL |
| ATORVASTATIN CALCIUM | ATORVASTATIN CALCIUM | EQ 10MG BASE | TABLET;ORAL |
| ATORVASTATIN CALCIUM | ATORVASTATIN CALCIUM | EQ 40MG BASE | TABLET;ORAL |
| ATORVASTATIN CALCIUM | ATORVASTATIN CALCIUM | EQ 20MG BASE | TABLET;ORAL |
4 products